TY - JOUR
T1 - Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours
AU - Gavish, Avishai
AU - Tyler, Michael
AU - Greenwald, Alissa C.
AU - Hoefflin, Rouven
AU - Simkin, Dor
AU - Tschernichovsky, Roi
AU - Galili Darnell, Noam
AU - Somech, Einav
AU - Barbolin, Chaya
AU - Antman, Tomer
AU - Kovarsky, Daniel
AU - Barrett, Thomas
AU - Gonzalez Castro, L. Nicolas
AU - Halder, Debdatta
AU - Chanoch-Myers, Rony
AU - Laffy, Julie
AU - Mints, Michael
AU - Wider, Adi
AU - Tal, Rotem
AU - Spitzer, Avishay
AU - Hara, Toshiro
AU - Raitses-Gurevich, Maria
AU - Stossel, Chani
AU - Golan, Talia
AU - Tirosh, Amit
AU - Suvà, Mario L.
AU - Puram, Sidharth V.
AU - Tirosh, Itay
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2023/6/15
Y1 - 2023/6/15
N2 - Each tumour contains diverse cellular states that underlie intratumour heterogeneity (ITH), a central challenge of cancer therapeutics 1. Dozens of recent studies have begun to describe ITH by single-cell RNA sequencing, but each study typically profiled only a small number of tumours and provided a narrow view of transcriptional ITH 2. Here we curate, annotate and integrate the data from 77 different studies to reveal the patterns of transcriptional ITH across 1,163 tumour samples covering 24 tumour types. Among the malignant cells, we identify 41 consensus meta-programs, each consisting of dozens of genes that are coordinately upregulated in subpopulations of cells within many tumours. The meta-programs cover diverse cellular processes including both generic (for example, cell cycle and stress) and lineage-specific patterns that we map into 11 hallmarks of transcriptional ITH. Most meta-programs of carcinoma cells are similar to those identified in non-malignant epithelial cells, suggesting that a large fraction of malignant ITH programs are variable even before oncogenesis, reflecting the biology of their cell of origin. We further extended the meta-program analysis to six common non-malignant cell types and utilize these to map cell–cell interactions within the tumour microenvironment. In summary, we have assembled a comprehensive pan-cancer single-cell RNA-sequencing dataset, which is available through the Curated Cancer Cell Atlas website, and leveraged this dataset to carry out a systematic characterization of transcriptional ITH.
AB - Each tumour contains diverse cellular states that underlie intratumour heterogeneity (ITH), a central challenge of cancer therapeutics 1. Dozens of recent studies have begun to describe ITH by single-cell RNA sequencing, but each study typically profiled only a small number of tumours and provided a narrow view of transcriptional ITH 2. Here we curate, annotate and integrate the data from 77 different studies to reveal the patterns of transcriptional ITH across 1,163 tumour samples covering 24 tumour types. Among the malignant cells, we identify 41 consensus meta-programs, each consisting of dozens of genes that are coordinately upregulated in subpopulations of cells within many tumours. The meta-programs cover diverse cellular processes including both generic (for example, cell cycle and stress) and lineage-specific patterns that we map into 11 hallmarks of transcriptional ITH. Most meta-programs of carcinoma cells are similar to those identified in non-malignant epithelial cells, suggesting that a large fraction of malignant ITH programs are variable even before oncogenesis, reflecting the biology of their cell of origin. We further extended the meta-program analysis to six common non-malignant cell types and utilize these to map cell–cell interactions within the tumour microenvironment. In summary, we have assembled a comprehensive pan-cancer single-cell RNA-sequencing dataset, which is available through the Curated Cancer Cell Atlas website, and leveraged this dataset to carry out a systematic characterization of transcriptional ITH.
UR - http://www.scopus.com/inward/record.url?scp=85160757861&partnerID=8YFLogxK
U2 - 10.1038/s41586-023-06130-4
DO - 10.1038/s41586-023-06130-4
M3 - Article
C2 - 37258682
AN - SCOPUS:85160757861
SN - 0028-0836
VL - 618
SP - 598
EP - 606
JO - Nature
JF - Nature
IS - 7965
ER -